These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9315598)

  • 1. Lipid-lowering therapy and long-term survival in heart transplantation.
    Stapleton DD; Mehra MR; Dumas D; Smart FW; Milani RV; Lavie CJ; Ventura HO
    Am J Cardiol; 1997 Sep; 80(6):802-5. PubMed ID: 9315598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gemfibrozil (Lopid) on hyperlipidemia in acitretin-treated patients. Results of a double-blind cross-over study.
    Vahlquist C; Olsson AG; Lindholm A; Vahlquist A
    Acta Derm Venereol; 1995 Sep; 75(5):377-80. PubMed ID: 8615057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gemfibrozil on serum levels of prostacyclin and precursor fatty acids in hyperlipidemic patients with Type 2 diabetes.
    Yoshinari M; Asano T; Kaori S; Shi AH; Wakisaka M; Iwase M; Fujishima M
    Diabetes Res Clin Pract; 1998 Dec; 42(3):149-54. PubMed ID: 9925344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperlipidemia after cardiac transplantation: be aware and possibly wary of drug therapy for lowering of serum lipids.
    Butman SM
    Am Heart J; 1991 May; 121(5):1585-90. PubMed ID: 2018001
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia.
    Lewis JE
    Angiology; 1982 Sep; 33(9):603-12. PubMed ID: 6957156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemfibrozil in hyperlipidaemia: an open, single blind trial.
    Varthakavi PK; Turakhia DP; Sharma SS; Salgaonkar DS; Nihalani KD; Joshi VR
    J Assoc Physicians India; 1990 Feb; 38(2):136-40. PubMed ID: 2380132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperlipidemia after renal transplantation: treatment with gemfibrozil.
    Chan TM; Cheng IK; Tam SC
    Nephron; 1994; 67(3):317-21. PubMed ID: 7936022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gemfibrozil in the treatment of hyperlipidemia].
    Wang JJ; Song YM; Wang YS; Lin WH
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb; 43(2):131-4. PubMed ID: 2766068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid status and linear relationship between total cholesterol and triglycerides in glycogen storage disease type I.
    Zhang ZJ; Yuan YH; Ma MS; Hong YH; Sun ZX; Xu YW; Wei M; Qiu ZQ
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10036-10044. PubMed ID: 33090409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gemfibrozil in the treatment of lipid metabolism disorders].
    Vartanova OA; Aleksandrovskaia TN; Shaldaeva VV
    Klin Med (Mosk); 1994; 72(1):37-41. PubMed ID: 8196321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of gemfibrozil upon the hypercoagulable state in dyslipidaemic patients with chronic renal failure.
    Irish AB; Thompson CH
    Nephrol Dial Transplant; 1996 Nov; 11(11):2223-8. PubMed ID: 8941582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for minimizing hyperlipidemia after cardiac transplantation.
    Kirklin JK; Benza RL; Rayburn BK; McGiffin DC
    Am J Cardiovasc Drugs; 2002; 2(6):377-87. PubMed ID: 14727953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins.
    Vega GL; Grundy SM
    JAMA; 1985 Apr; 253(16):2398-403. PubMed ID: 3856692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemfibrozil, stretching arms beyond lipid lowering.
    Roy A; Pahan K
    Immunopharmacol Immunotoxicol; 2009; 31(3):339-51. PubMed ID: 19694602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A long-term study on blood lipids after gemfibrozil].
    Lu Z
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):369-71. PubMed ID: 1821353
    [No Abstract]   [Full Text] [Related]  

  • 16. [Helsinki Heart Study].
    Sekiya M; Ishibashi S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():404-9. PubMed ID: 11347103
    [No Abstract]   [Full Text] [Related]  

  • 17. Safe use of gemfibrozil in uremic patients on continuous ambulatory peritoneal dialysis.
    Lucatello A; Sturani A; Di Nardo AM; Cocchi R; Fusaroli M
    Nephron; 1998; 78(3):338. PubMed ID: 9546699
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of diet and gemfibrozil on posttransplant hyperlipidemia in renal transplant recipients.
    Sapan M; Ozben B; Yakupoglu G; Suleymanlar G; Ozben T
    J Investig Med; 2009 Feb; 57(2):456-9. PubMed ID: 19174703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
    Wolf HR
    Drugs Exp Clin Res; 1994; 20(3):109-13. PubMed ID: 7956717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of fenofibrate or gemfibrozil on serum lipid profiles in Chinese patients with type IIb hyperlipidemia: a single-blind, randomized, and cross-over study.
    Jen SL; Chen JW; Lee WL; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Apr; 59(4):217-24. PubMed ID: 9216117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.